Julian Schink, MD, Named Chief Medical Officer of Cancer Treatment Centers of America

Corporate | January 8, 2019

Julian Schink, MD, has been appointed Chief Medical Officer of Cancer Treatment Centers of America® (CTCA). Dr. Schink, a nationally-renowned gynecologic oncologist, brings a wealth of clinical leadership to this role.

Dr. Schink joined CTCA® in May 2017 as Chief of Gynecologic Oncology and serves in a regional clinical leadership capacity at CTCA Chicago where he also cares for patients at both the CTCA Comprehensive Care and Research Center (CCRC) in Zion, Illinois and the Downtown Chicago Outpatient Cancer Center (OCC). As Chief Medical Officer for the comprehensive cancer care network, Dr. Schink will report to Maurie Markman, MD, President, CTCA Medicine & Science.

“Julian’s appointment signals CTCA’s continued focus on our incomparable delivery of the Mother Standard® of care and our goal to ensure maximum effort is put toward patient care, treatment options, clinical programs, quality, outcomes and critical external relationships that hold clinical value in high regard,” Dr. Markman said.

As Chief Medical Officer, Dr. Schink will provide leadership and direction for CTCA’s enterprise-wide clinical programs and serve as a liaison between physicians and administrative leaders across the enterprise.

“I am excited to take on this new challenge,” Dr. Schink said. “I’m thrilled to work with my talented colleagues across the enterprise and am laser-focused on the opportunities we have to expand access to innovative treatment options and compassionate care for patients across the U.S. and internationally.”

Dr. Schink received his Doctor of Medicine degree from the University of Texas Health Science Center at San Antonio. After medical school, he completed his residency training in obstetrics and gynecology at Northwestern University Medical School, followed by a fellowship in gynecologic oncology at the University of California, Los Angeles Medical School.

Dr. Schink has held numerous academic positions, including vice chair of obstetrics and gynecology and professor at the University of Wisconsin Medical School; and subsequently an endowed professorship at Northwestern University Feinberg School of Medicine as the John I Brewer Professor of gynecology and cancer research.

Dr. Schink has been published in numerous medical journals including more than 125 publications in oncology and women’s health. He has authored chapters in oncology textbooks, particularly focusing on gestational trophoblastic disease. He has also served as principal investigator and co-investigator for many large clinical trials responsible for improving and expanding cancer treatment options.

Dr. Schink has been a member of and held leadership positions at several medical organizations, including the American College of Obstetricians & Gynecologists, the Society of Gynecologic Oncologists and the Gynecologic Cancer Foundation. Dr. Schink has also won several awards for his outstanding work, including listings in America’s Top Doctors, The Best Doctors in America and Chicago Super Doctors.

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.